Pricing Log in Create free account
Friday 6 November 2026 Export PRGO’s income statement to Excel — free account

Perrigo Company plc

PRGO Healthcare Drug Manufacturers Specialty & Generic

Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.

Revenue
−5.24%
EPS
−494.6%
Free cash flow
+138.5%
Total debt
−9.62%

Quarter to September 2026, against a year earlier

15.66 0.17 −1.07%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−7.2×
Dividend yield
7.41%
F-score
4/9
Altman Z
−0.08
Beneish M
−3.51
Dividend safety
16/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Perrigo Company plc (PRGO) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Perrigo Company plc (PRGO) trades at a EV/Sales of 1.2×. Over the past ten years it has ranged from 1.0× (July 2026) to 10.4× (January 2016); the current reading is higher than 8% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.9× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.2× (21.44%)
FY2024 1.5× (10.15%)
FY2023 1.7× (9.39%)
FY2022 1.9× 11.82%
FY2021 1.7× (24.96%)
FY2020 2.2× (14.97%)
FY2019 2.6× 52.87%
FY2018 1.7× (45.57%)
FY2017 3.1× (6.28%)
FY2016 3.3× (67.18%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.2× 14.75%
Jun 2026 1.0× (8.17%)
Mar 2026 1.1× (3.70%)
Dec 2025 1.2× (19.48%)
43 more quarters

Against its own ten years

Low 1.0× High 10.4×
Ten-year median 2.1×
Current reading's percentile 9

EV/Sales against peers

Company EV/Sales
HCM HUTCHMED (China) Limited Sponsored ADR compare −0.1×
RGC Regencell Bioscience Holdings Limited compare n/m
PRGO Perrigo Company plc 1.2×
ANIP ANI Pharmaceuticals, Inc. compare 1.6×
TRLV Trulieve Cannabis Corp. compare 2.0×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.5×
PBH Prestige Consumer Healthcare Inc. compare 3.5×
XERS Xeris Biopharma Holdings, Inc. compare 6.7×
ALVO Alvotech compare 8.6×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PRGO